Topic - Turing Pharmaceuticals

Related Stories

Fire alarm, protests disrupt ex-pharma exec Shkreli’s talk

Associated Press

Harvard students protest ex-pharma exec Shkreli’s talk

Associated Press

Ex-drug company CEO Martin Shkreli to speak at Harvard

Associated Press

Senators urge action to block drastic drug price hikes

By MATTHEW PERRONE - Associated Press

Former Turing Pharmaceuticals CEO Martin Shkreli, center, leaves court with his lawyer Benjamin Brafman, left, Wednesday, Feb. 3, 2016, in New York. Shkreli, who has become the poster child of pharmaceutical-industry greed after hiking the price of an anti-infection drug by more than 5,000 percent, is scheduled to appear at a congressional hearing on Thursday. (AP Photo/Seth Wenig)

Martin Shkreli, ‘pharma bro,’ rebuffs Congress through silence

By Tom Howell Jr. - The Washington Times

In this Dec. 17, 2015, file photo, Martin Shkreli leaves the courthouse after his arraignment in New York. (AP Photo/Seth Wenig, File)

Martin Shkreli gets extra time to fight Congress

By Tom Howell Jr. - The Washington Times

FILE - In this Dec. 17, 2015 file photo, Martin Shkreli, the former hedge fund manager under fire for buying a pharmaceutical company and ratcheting up the price of a life-saving drug, is escorted by law enforcement agents in New York after being taken into custody following a securities probe. Shkreli has resigned as the head of one of the companies he now runs, Turing Pharmaceuticals, on Friday, Dec. 18, 2015.(AP Photo/Craig Ruttle)

Martin Shkreli, Turing Pharmaceuticals CEO, resigns

By Andrea Noble - The Washington Times

Martin Shkreli, the former hedge fund manager under fire for buying a pharmaceutical company and ratcheting up the price of a life-saving drug, is belted into an awaiting car after being taken into custody following a securities probe, on Thursday, Dec. 17, 2015 in New York. A seven-count indictment unsealed in Brooklyn federal court Thursday charged Shkreli with conspiracy to commit securities fraud, conspiracy to commit wire fraud and securities fraud. (AP Photo/Craig Ruttle)

Martin Shkreli, Turing CEO and former hedge fund manager, charged with securities fraud

By Andrea Noble - The Washington Times